The Pharmacological Role of Ginsenoside Rg3 in Liver Diseases: A Review on Molecular Mechanisms

Overview

Journal J Ginseng Res

Date 2024 Mar 11

PMID 38465219

Authors

Wenhong Wang

Ke Li

Weihua Xiao

Affiliations

Soon will be listed here.

Abstract

Liver diseases are a significant global health burden and are among the most common diseases. Ginssennoside Rg3 (Rg3), which is one of the most abundant ginsenosides, has been found to have significant preventive and therapeutic effects against various types of diseases with minimal side effects. Numerous studies have demonstrated the significant preventive and therapeutic effects of Rg3 on various liver diseases such as viral hepatitis, acute liver injury, nonalcoholic liver diseases (NAFLD), liver fibrosis and hepatocellular carcinoma (HCC). The underlying molecular mechanism behind these effects is attributed to apoptosis, autophagy, antioxidant, anti-inflammatory activities, and the regulation of multiple signaling pathways. This review provides a comprehensive description of the potential molecular mechanisms of Rg3 in the development of liver diseases. The article focuses on the regulation of apoptosis, oxidative stress, autophagy, inflammation, and other related factors. Additionally, the review discusses combination therapy and liver targeting strategy, which can accelerate the translation of Rg3 from bench to bedside. Overall, this article serves as a valuable reference for researchers and clinicians alike.

Citing Articles

Molecular mechanisms behind the inhibitory effects of ginsenoside Rg3 on hepatic fibrosis: a review.

Tian Z, Hu R, Wang Z, Wang Y, Li W Arch Toxicol. 2024; 99(2):541-561.

PMID: 39729114 DOI: 10.1007/s00204-024-03941-w.

Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.

Wu J, Tang G, Cheng C, Yeerken R, Chan Y, Fu Z Mol Cancer. 2024; 23(1):218.

PMID: 39354529 PMC: 11443773. DOI: 10.1186/s12943-024-02136-2.

References

Yu Y, Zhang C, Liu L, Li X . Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Exp Ther Med. 2013; 5(3):761-766. PMC: 3570116. DOI: 10.3892/etm.2012.873. View

He S, Tian S, He X, Le X, Ning Y, Chen J . Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma. Mol Ther Oncolytics. 2021; 22:604-616. PMC: 8449031. DOI: 10.1016/j.omto.2021.08.008. View

Yan M, Diao M, Zhang C, Shen X, Zhan X, Xi C . Lactoferrin-ginsenoside Rg3 complex ingredients: Study of interaction mechanism and preparation of oil-in-water emulsion. Food Chem. 2021; 363:130239. DOI: 10.1016/j.foodchem.2021.130239. View

Gum S, Cho M . The amelioration of N-acetyl-p-benzoquinone imine toxicity by ginsenoside Rg3: the role of Nrf2-mediated detoxification and Mrp1/Mrp3 transports. Oxid Med Cell Longev. 2013; 2013:957947. PMC: 3666202. DOI: 10.1155/2013/957947. View

Dewidar B, Meyer C, Dooley S, Meindl-Beinker A . TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells. 2019; 8(11). PMC: 6912224. DOI: 10.3390/cells8111419. View

Lee J, Jung K, Morgan M, Kang Y, Lee H, Koo G . Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol Cancer Ther. 2012; 12(3):274-85. DOI: 10.1158/1535-7163.MCT-12-0054. View

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. DOI: 10.3322/caac.20121. View

Maceyka M, Spiegel S . Sphingolipid metabolites in inflammatory disease. Nature. 2014; 510(7503):58-67. PMC: 4320971. DOI: 10.1038/nature13475. View

Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X . Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep. 2012; 5(5):1295-8. DOI: 10.3892/mmr.2012.808. View

10.

Yoo Y, Lee J, Park S, Nam K, Cho Y, Choi J . Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J Ginseng Res. 2013; 37(1):80-6. PMC: 3659615. DOI: 10.5142/jgr.2013.37.80. View

11.

Khomich O, Ivanov A, Bartosch B . Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells. 2019; 9(1). PMC: 7016711. DOI: 10.3390/cells9010024. View

12.

Xie Y . Hepatitis B Virus-Associated Hepatocellular Carcinoma. Adv Exp Med Biol. 2017; 1018:11-21. DOI: 10.1007/978-981-10-5765-6_2. View

13.

Chen K, Chen H, Tai W, Feng W, Hsu C, Chen P . Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2011; 337(1):155-61. DOI: 10.1124/jpet.110.175786. View

14.

Hu S, Zhu Y, Xia X, Xu X, Chen F, Miao X . Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis. Anal Cell Pathol (Amst). 2019; 2019:3815786. PMC: 6732603. DOI: 10.1155/2019/3815786. View

15.

Kang L, Choi Y, Lee S . Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol. 2013; 45(11):2612-21. DOI: 10.1016/j.biocel.2013.08.016. View

16.

Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F . HCV virology and diagnosis. Clin Res Hepatol Gastroenterol. 2021; 45(3):101626. DOI: 10.1016/j.clinre.2021.101626. View

17.

Masoodi M, Gastaldelli A, Hyotylainen T, Arretxe E, Alonso C, Gaggini M . Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat Rev Gastroenterol Hepatol. 2021; 18(12):835-856. DOI: 10.1038/s41575-021-00502-9. View

18.

Park H, Kim S, Mun A, Go H, Kim G, Kim S . Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells. J Ethnopharmacol. 2012; 141(3):1071-6. DOI: 10.1016/j.jep.2012.03.038. View

19.

Teng S, Wang Y, Li P, Liu J, Wei A, Wang H . Effects of R type and S type ginsenoside Rg3 on DNA methylation in human hepatocarcinoma cells. Mol Med Rep. 2017; 15(4):2029-2038. PMC: 5364960. DOI: 10.3892/mmr.2017.6255. View

20.

Arrese M, Cabrera D, Kalergis A, Feldstein A . Innate Immunity and Inflammation in NAFLD/NASH. Dig Dis Sci. 2016; 61(5):1294-303. PMC: 4948286. DOI: 10.1007/s10620-016-4049-x. View